MiniVax

MiniVax

Verified
MiniVax is focused on the development of solutions for the treatment and prevention of opportunistic infections.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$440—660k (Dealroom.co estimates May 2013.)
New Orleans Louisiana (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

$0.0

round
N/A

$110k

Seed
Total Funding000k

Recent News about MiniVax

Edit